Exciting News: we have acquired Illumina DRAGEN (Dynamic Read Analysis for GENomics)

We are thrilled to announce that our Genomics Core Facility has acquired the Illumina DRAGEN Bio-IT Platform, a cutting-edge tool that will significantly enhance our genomic analysis capabilities.

Benefits of DRAGEN:

Speed: DRAGEN accelerates data processing, allowing us to analyse genomic data faster than ever before.

Accuracy: With advanced algorithms, DRAGEN ensures highly accurate results, improving the reliability of our data analysis results.

Efficiency: The platform optimizes computational resources, making our workflows more efficient and cost-effective.

Scalability: DRAGEN can handle large-scale genomic projects, supporting our growing research needs.

The acquisition of DRAGEN will enable us to tackle more complex genomic challenges and produce faster high-quality data.